Cite
HARVARD Citation
Lim, S. et al. (n.d.). P554 Vedolizumab Associated quality of Life and inflammatory bowel disease control Upon Entering a subcutaneous switching program (VALUE) – Results from a multi-centre UK study. Journal of Crohn's and colitis. pp. i499-i500. [Online].